Cargando…
Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography
The two main screening tests during pregnancy are those for chromosomal abnormalities and neural tube defects (NTDs). In particular, for NTDs, measurement of maternal serum alpha-fetoprotein (MSAFP) levels early in the second trimester (15–18 weeks of gestation) has been considered the gold standard...
Autores principales: | Kim, Gwang Jun, Seong, Ji Su, Oh, Jin A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Obstetrics and Gynecology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849725/ https://www.ncbi.nlm.nih.gov/pubmed/36575050 http://dx.doi.org/10.5468/ogs.22263 |
Ejemplares similares
-
Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023) -
Neural tube defects--prenatal diagnosis and management.
por: Hamilton, R. A., et al.
Publicado: (1992) -
External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days
por: Chen, Yiming, et al.
Publicado: (2022) -
Point-of-Care Quantification of Serum Alpha-Fetoprotein for Screening Birth Defects in Resource-Limited Settings: Proof-of-Concept Study
por: Srinivasan, Balaji, et al.
Publicado: (2020) -
Epidemiology, prenatal management, and prevention of neural tube defects
por: Salih, Mustafa A., et al.
Publicado: (2014)